Citi cuts Hims & Hers target, opens ‘downside short-term view’
Citi lowered the firm’s price target on Hims Hers to $25 from $27 and keeps a Sell rating on…
24,190€
-2,30%
Echtzeit-Aktienkurs Hims & Hers Health Inc.
Bid:
Ask:
Nachrichten zur Hims & Hers Health Inc. Aktie
Hims & Hers: Look Past Near-Term GLP-1 Risks, This Is A Great Dip To Buy
…
Sell Rating Issued for Hims & Hers Health Amid FDA Concerns on Topical Finasteride
Bank of America Securities analyst Allen Lutz maintained a Sell rating on Hims & Hers Health (HIMS – Research Report)…
2 Reasons to Like HIMS and 1 to Stay Skeptical
Since April 2020, the S&P 500 has delivered a total return of 92.9%. But one standout stock has nearly doubled…
Hims & Hers Stock (HIMS) Dips After FDA Flags Safety Concerns
Hims Hers Health ($HIMS) stock declined about 2% yesterday. The fall came after the U.S. Food and Drug Administration…
Hims Hers Health stock falls on FDA warning By Investing.com
Hims Hers Health stock falls on FDA warning…
Hims Hers Health stock falls on FDA warning By Investing.com
Hims Hers Health stock falls on FDA warning…
FDA issues warning on hair-loss treatment sold on Hims & Hers
The FDA warning letter doesn’t prevent the company from continuing to sell the treatment, but may be a sign of…
Is Most-Watched Stock Hims & Hers Health, Inc. (HIMS) Worth Betting on Now?
Recently, Zacks.com users have been paying close attention to Hims & Hers Health (HIMS). This makes it worthwhile to examine…
Zacks Industry Outlook Highlights Veeva Systems, Hims & Hers Health and Butterfly Network
Veeva Systems, Hims & Hers Health and Butterfly Network are part of the Zacks Industry Outlook article.…
Zacks Industry Outlook Highlights Veeva Systems, Hims & Hers Health and Butterfly Network
For Immediate ReleaseChicago, IL – April 22, 2025 – Today, Zacks Equity Research discusses Veeva Systems VEEV, Hims & Hers…
Is Hims & Hers Health, Inc. (HIMS) the Best Telehealth Stock to Buy Now?
We recently published a list of 10 Best Telehealth Stocks to Buy Now. In this article, we are going to…
Is Hims & Hers Health, Inc. (HIMS) the Best Telehealth Stock to Buy Now?
We recently published a list of 10 Best Telehealth Stocks to Buy Now. In this article, we are going to…
Hims & Hers Health COO Plans to Leave
Hims & Hers Health disclosed in a regulatory filing on Monday that Chief Operating Officer Melissa Baird plans to…
Hims & Hers Health COO Transition to Advisory Role
Hims & Hers Health ( ($HIMS) ) just unveiled an announcement. On April 21, 2025, Melissa Baird, the Chief Operating…
Hims & Hers COO to transition to advisory role
Hims & Hers Health (NYSE:HIMS) said on Monday that Melissa Baird, Chief Operating Officer of the company, has announced her…
Hims & Hers COO to Transition into Advisory Role By Investing.com
Hims & Hers COO to Transition into Advisory Role…
Hims & Hers COO to Transition into Advisory Role By Investing.com
Hims & Hers COO to Transition into Advisory Role…
Hims & Hers: Top Pick For The Next Decade
…
Hims & Hers: Top Pick For The Next Decade (NYSE:HIMS)
Hims & Hers has shown explosive growth, with potential revenue of $2.5B in FY25, trading at a low 2.4x FY25 sales. Learn…
Hims & Hers Health and AST SpaceMobile have been highlighted as Zacks Bull and Bear of the Day
Hims & Hers Health and AST SpaceMobile are part of the Zacks Bull and Bear of the Day article.…
Hims & Hers Health and AST SpaceMobile have been highlighted as Zacks Bull and Bear of the Day
For Immediate ReleaseChicago, IL – April 21, 2025 – Zacks Equity Research shares Hims & Hers Health HIMS as the…
Hims & Hers Health and AST SpaceMobile have been highlighted as Zacks Bull and Bear of the Day
Hims & Hers Health and AST SpaceMobile are part of the Zacks Bull and Bear of the Day article.…
Comeback-Kandidat im Fokus: Hims & Hers Health mit erster Stabilisierung
Anzeige / WerbungDie Aktie von Hims & Hers Health (ISIN: US4330001060) galt lange als Highflyer unter den wachstumsstarken Digital-Health-Werten -…
Bull of the Day: Hims & Hers Health (HIMS)
Hims & Hers Health (HIMS) has emerged as a disruptive force in telehealth, leveraging technology and personalization to address highly-personal…
Hims & Hers Health, Inc. (HIMS) Surpasses Market Returns: Some Facts Worth Knowing
In the closing of the recent trading day, Hims & Hers Health, Inc. (HIMS) stood at $27.23, denoting a +1.04%…
Hims & Hers Health, Inc. (HIMS) Surpasses Market Returns: Some Facts Worth Knowing
In the closing of the recent trading day, Hims & Hers Health, Inc. (HIMS) stood at $27.23, denoting a +1.04%…
Healthcare Technology Stocks Q4 In Review: Hims & Hers Health (NYSE:HIMS) Vs Peers
Let’s dig into the relative performance of Hims & Hers Health (NYSE: HIMS) and its peers as we unravel the…
Healthcare Technology Stocks Q4 In Review: Hims & Hers Health (NYSE:HIMS) Vs Peers
Let’s dig into the relative performance of Hims & Hers Health (NYSE:HIMS) and its peers as we unravel the now-completed…
Healthcare Technology Stocks Q4 In Review: Hims & Hers Health (NYSE:HIMS) Vs Peers
Detailed price information for Hims & Hers Health Inc (HIMS-N) from The Globe and Mail including charting and trades.…
Why Hims & Hers Health, Inc. (HIMS) Declined on Wednesday
The stock market fell sharply anew on Wednesday, with all major indices ending in the red, as investor sentiment was…
Why Hims & Hers Health, Inc. (HIMS) Declined on Wednesday
The stock market fell sharply anew on Wednesday, with all major indices ending in the red, as investor sentiment was…
BofA maintains Hims & Hers stock underperform with $22 target By Investing.com
BofA maintains Hims & Hers stock underperform with $22 target…
BofA maintains Hims & Hers stock underperform with $22 target By Investing.com
BofA maintains Hims & Hers stock underperform with $22 target…
Hims & Hers health CFO sells $330,081 in stock By Investing.com
Hims & Hers health CFO sells $330,081 in stock…
Hims & Hers health CFO sells $330,081 in stock By Investing.com
Hims & Hers health CFO sells $330,081 in stock…
Hims & Hers health CFO sells $330,081 in stock By Investing.com
Hims & Hers health CFO sells $330,081 in stock…
Hims & Hers health chief legal officer sells $280,314 in stock By Investing.com
Hims & Hers health chief legal officer sells $280,314 in stock…
Hims & Hers Health, Inc. (HIMS): A Bull Case Theory
We came across a bullish thesis on Hims & Hers Health, Inc. (HIMS) on wallstreetbets Subreddit Page by MostCapital5741. In…
Hims & Hers Health, Inc. (HIMS): A Bull Case Theory
We came across a bullish thesis on Hims & Hers Health, Inc. (HIMS) on wallstreetbets Subreddit Page by MostCapital5741. In this article,…
Hims & Hers Stock Gains 5.8% in 3 Months: Heres How to Play it
HIMS is enhancing offerings and expanding its health and wellness products and services to solidify its footing. However, macro challenges…
Hims & Hers Stock Gains 5.8% in 3 Months: Heres How to Play it
Hims & Hers Health, Inc.’s HIMS investors have been experiencing some short-term gains from the stock of late, which are…
Hims & Hers Stock Gains 5.8% in 3 Months: Heres How to Play it
Hims & Hers Health, Inc.’s HIMS investors have been experiencing some short-term gains from the stock of late, which are…
HIMS Stock: Ready To Bounce Back From $30?
Hims & Hers Health (NYSE: HIMS), a telehealth platform, has taken a beating recently, with shares plummeting 60% from February…
BofA keeps Hims & Hers stock at underperform, target at $22 By Investing.com
BofA keeps Hims & Hers stock at underperform, target at $22…
BofA keeps Hims & Hers stock at underperform, target at $22 By Investing.com
BofA keeps Hims & Hers stock at underperform, target at $22…
BofA keeps Hims & Hers stock at underperform, target at $22 By Investing.com
BofA keeps Hims & Hers stock at underperform, target at $22…
Sell Rating for Hims & Hers Health Due to Slowing Sales Growth and Regulatory Risks
In a report released today, Allen Lutz from Bank of America Securities reiterated a Sell rating on Hims & Hers…
HIMS Stock: Ready To Bounce Back From $30?
Hims & Hers Health (NYSE: HIMS), a telehealth platform, has taken a beating recently, with shares plummeting 60% from February…
Lobbying Update: $60,000 of HIMS & HERS HEALTH INC. lobbying was just disclosed
$60,000 of HIMS & HERS HEALTH INC. lobbying was just disclosed, from Q1 of 2025, in a new Lobbying Disclosure…